Hospital readmission rates and risk factors for readmission following cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal surface malignancies-Reference-Cited by-同舟云学术

Hospital readmission rates and risk factors for readmission following cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal surface malignancies

Published:2018-10 Issue:5 Volume:16 Page:278-282
ISSN:1479-666X
Container-title:The Surgeon
language:en
Short-container-title:The Surgeon

Author:

Dreznik Yael^ORCID,Hoffman Aviad,Hamburger Tamar,Ben-Yaacov Almog,Dux Yossi,Jacoby Harel,Berger Yaniv,Nissan Aviram,Gutman Mordechai

Publisher

Elsevier BV

Subject

Surgery

Reference18 articles.

1. Exploring the burden of inpatient admissions after major cancer surgery;Stitzenberg;J Clin Oncol,2015

2. Factors influencing readmission after pancreaticoduodenectomy: a multi institutional study of 1302 patients;Ahmad;Ann Surg,2012

3. Influence of patient, physician, and hospital factors on 30-day readmission following pancreaticoduodenectomy in the United States;Hyder;JAMA surg,2013

4. Why are patients being readmitted after surgery for esophageal cancer?;Shah;J Thorac Cardiovasc Surg,2015

5. Readmission after pancreatic resection: causes and causality patterns;Sadot;Ann Surg Oncol,2014

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Weekend Discharge Is Not Associated With Increased Readmission After Hyperthermic Intraperitoneal Chemotherapy;Journal of Surgical Research;2024-01

2. Complications and Mortality Rate of Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy: Italian Peritoneal Surface Malignancies Oncoteam Results Analysis;Cancers;2022-11-25

3. Randomized Controlled Trial Investigating Perioperative Immunonutrition for Patients Undergoing Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC);Annals of Surgical Oncology;2022-09-30

4. Predictors of Small Bowel Obstruction Post-Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy;Journal of Gastrointestinal Surgery;2022-06-29

5. Predicting Early and Late Readmissions Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy;Annals of Surgical Oncology;2021-07-24